Anadeo, Liezel .
HRN: 23-84-48 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/13/2023
IV
1.5gm
Q8
Repeat CS
Waiting Final Action
10/07/2023
CEFUROXIME 500MG (TAB)
10/07/2023
10/14/2023
PO
500mg
BID
Repeat CS
Waiting Final Action